Bimzelx 320 MG/2 ML autoinject 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0A3N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,531
Award facts
- Contract value 100% obligated
- $40,530.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,530.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 26, 2026, for the supply of BIMZELX 320 MG/2 ML auto-injector units. The order is set to be completed by January 27, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, demonstrating the contractor's capability to meet federal procurement requirements in open competition. The award is issued under AmerisourceBergen's parent company, Cencora, Inc. (UEI: NWEGNLYTBDW4), which holds a substantial indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for military healthcare systems and federal medical procurement initiatives. The company's comprehensive IDC vehicle enables it to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities to support military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This delivery order for BIMZELX, a specialty pharmaceutical product, reflects the contractor's ongoing role in fulfilling specialized medical supply requirements within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F0A3N?
SPE2DR26F0A3N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F0A3N worth?
The government has obligated $40,531 on SPE2DR26F0A3N.
Is contract SPE2DR26F0A3N an order under another contract?
Yes. SPE2DR26F0A3N is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A3N competed?
The extent of competition for SPE2DR26F0A3N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award